RSV and Influenza

作者: Birgit von Hoersten , Mike Sharland

DOI: 10.1007/978-1-4419-8993-2_23

关键词:

摘要: Clinical and experimental studies have demonstrated that the pathophysiology of RSV infection is largely due to host responses rather than cytopathic effects virus. Therefore use anti-inflammatory agents such as steroids appears be an attractive therapeutic option. This has been studied extensively a recent meta-analysis concludes does not reduce length stay in hospital by clinically relevant time (Garrison et al., 2000). A further multicenter RCT study using intravenous Dexamethasone patients admitted PICU also did demonstrate effect hospital. subgroup analysis young infants with bronchiolitis suggested reduction duration ventilation (van Woensel 2003).

参考文章(29)
Caroline Breese Hall, R Dolin, Christine L Gala, David M Markovitz, Yu Qin Zhang, Paul H Madore, Frank A Disney, William B Talpey, John L Green, Anne B Francis, Michael E Pichichero, Children with influenza A infection: treatment with rimantadine. Pediatrics. ,vol. 80, pp. 275- 282 ,(1987)
Robert S. Zeiger, Current issues with influenza vaccination in egg allergy The Journal of Allergy and Clinical Immunology. ,vol. 110, pp. 834- 840 ,(2002) , 10.1067/MAI.2002.129372
Kathleen Maletic Neuzil, Beverly G. Mellen, Peter F. Wright, Edward F. Mitchel, Marie R. Griffin, The Effect of Influenza on Hospitalizations, Outpatient Visits, and Courses of Antibiotics in Children New England Journal of Medicine. ,vol. 342, pp. 225- 231 ,(2000) , 10.1056/NEJM200001273420401
Steven Joffe, G. Thomas Ray, Gabriel J. Escobar, Steven B. Black, Tracy A. Lieu, Cost-effectiveness of respiratory syncytial virus prophylaxis among preterm infants. Pediatrics. ,vol. 104, pp. 419- 427 ,(1999) , 10.1542/PEDS.104.3.419
SHANE M. TIBBY, MARK HATHERILL, SARAH M. WRIGHT, PETER WILSON, ANTHONY D. POSTLE, IAN A. MURDOCH, Exogenous surfactant supplementation in infants with respiratory syncytial virus bronchiolitis. American Journal of Respiratory and Critical Care Medicine. ,vol. 162, pp. 1251- 1256 ,(2000) , 10.1164/AJRCCM.162.4.9909004
PEDRO A. PIEDRA, Clinical experience with respiratory syncytial virus vaccines. Pediatric Infectious Disease Journal. ,vol. 22, ,(2003) , 10.1097/01.INF.0000053893.15894.FF
G. Boivin, I. Hardy, G. Tellier, J. Maziade, Predicting Influenza Infections during Epidemics with Use of a Clinical Case Definition Clinical Infectious Diseases. ,vol. 31, pp. 1166- 1169 ,(2000) , 10.1086/317425
JAMES A. HEDRICK, ASHER BARZILAI, ULRICH BEHRE, FREDERICK W. HENDERSON, JANET HAMMOND, LUCY REILLY, OLIVER KEENE, Zanamivir for treatment of symptomatic influenza A and B infection in children five to twelve years of age: a randomized controlled trial. Pediatric Infectious Disease Journal. ,vol. 19, pp. 410- 417 ,(2000) , 10.1097/00006454-200005000-00005
KATHLEEN M. NEUZIL, WILLIAM D. DUPONT, PETER F. WRIGHT, KATHRYN M. EDWARDS, Efficacy of inactivated and cold-adapted vaccines against influenza A infection, 1985 to 1990: the pediatric experience. Pediatric Infectious Disease Journal. ,vol. 20, pp. 733- 740 ,(2001) , 10.1097/00006454-200108000-00004